Pfizer fails to provide emergency penicillin donations as Trump administration seeks policy change to curb drugmaker price avoidance

Pfizer has not complied with a request from state health agencies to donate emergency penicillin, a measure intended to act as a backstop against congenital syphilis.

The shortfall underscores ongoing difficulties in securing drug access for public‑health emergencies, according to the column.

At the same time, the Trump administration has proposed changing a rule that was meant to prevent drugmakers from avoiding Medicare price negotiations, aiming to tighten pricing oversight. The piece also briefly mentions a Sanofi diabetes drug without further detail.